Criticalkare Pharma

Fasenra 30mg Injection 1ml belongs to a class of drugs called interleukin inhibitors containing the active ingredient Benralizumab. Fasenra injection is used to treat severe eosinophilic asthma, a subtype of asthma caused by high levels of eosinophils in the blood and airways. It is also approved for treating eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease affecting blood vessels and organs.
Before using fasenra injection, it's essential to talk to your doctor if you have a history of allergic reactions to certain injections or medicines, have a parasitic infection, and live in an area where parasitic infections are common because this drug may weaken your ability to fight certain types of parasitic infections. If your asthma remains uncontrolled or worsens during treatment, immediately discuss this with your physician. This medicine is not intended to treat sudden asthma attacks. It should not be used as a rescue medication in such situations.
Do not use Fasenra 30mg Injection 1ml unless your doctor advises. Notify your physician if you are pregnant or planning to have a baby or think you may be pregnant so that your doctor may decide to give you this medicine if the expected benefits outweigh any potential risks. 
It is unknown whether Fasenra injection passes into breast milk and is safe to administer during breastfeeding. Inform your physician if you are a nursing mother. This medicine is not recommended for use in children under 18 because the safety and benefits of this medication have not been established in this age group. Parents and caregivers should consult physicians for appropriate asthma management and treatment options for children and adults.

Uses
Treatment of severe eosinophilic asthma

Storage
Store Fasenra 30mg Injection 1ml in a refrigerator at 2°C-8°C.Do not freeze

Side Effects
Hypersensitivity reactionsHeadacheSore throatRashesFeverInjection site reactionsMuscle pain